147 related articles for article (PubMed ID: 36090469)
1. Clinical Features Analysis and Survival Nomogram of Primary Small Intestinal Diffuse Large B-Cell Lymphoma.
Liu X; Cao D; Liu H; Ke D; Ke X; Xu X
Cancer Manag Res; 2022; 14():2639-2648. PubMed ID: 36090469
[TBL] [Abstract][Full Text] [Related]
2. A validated survival nomogram for early-onset diffuse gastric cancer.
Liao F; Guo X; Lu X; Dong W
Aging (Albany NY); 2020 Jul; 12(13):13160-13171. PubMed ID: 32639946
[TBL] [Abstract][Full Text] [Related]
3. Prognostic nomogram for primary splenic lymphoma: a SEER database-based study.
Chen F; Long H; Ding J; Ren J; Qu B; Cao P; Wang Z; Wu Z; Ma Q; Ma Z
Am J Cancer Res; 2023; 13(12):5825-5845. PubMed ID: 38187057
[TBL] [Abstract][Full Text] [Related]
4. What factors are associated with the prognosis of primary testicular diffuse large B-cell lymphoma? A study based on the SEER database.
Yang S; Chang W; Zhang B; Shang P
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10269-10278. PubMed ID: 37270733
[TBL] [Abstract][Full Text] [Related]
5. Nomogram for Predicting the Overall Survival of Adult Patients With Primary Gastrointestinal Diffuse Large B Cell Lymphoma: A SEER- Based Study.
Wang J; Zhou M; Zhou R; Xu J; Chen B
Front Oncol; 2020; 10():1093. PubMed ID: 32719748
[No Abstract] [Full Text] [Related]
6. Development and External Validation of a Nomogram to Predict Cancer-Specific Survival in Patients with Primary Intestinal Non-Hodgkin Lymphomas.
Zhang C; Liu Z; Tao J; Lin L; Zhai L
Cancer Manag Res; 2021; 13():9271-9285. PubMed ID: 34992453
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a survival nomogram in patients with primary testicular diffuse large B-cell lymphoma.
Zhi Y; Bao S; Mao J; Chai G; Liu C; Zhu J
J Int Med Res; 2023 Sep; 51(9):3000605231197052. PubMed ID: 37676929
[TBL] [Abstract][Full Text] [Related]
8. Benefits of Dynamic Nomogram Models for Elderly Diffuse Large B-Cell Lymphoma Patients' Early Death Prediction and Clinical Application.
Zhang L; Jing H; Tang S; Wang J; Yang P
Mediators Inflamm; 2023; 2023():7874239. PubMed ID: 37096156
[TBL] [Abstract][Full Text] [Related]
9. A Novel Prognostic Model for Patients with Primary Gastric Diffuse Large B-Cell Lymphoma.
Lu G; Lin Z; Ruan Y; Huang H; Lin J; Pan J
J Oncol; 2022; 2022():9636790. PubMed ID: 36339648
[TBL] [Abstract][Full Text] [Related]
10. Establishment of Prognosis Nomogram for Primary Splenic Diffuse Large B Cell Lymphoma: A Study Based on SEER Database.
Yonghao O; Yongyang W; Siqing Y; Chengchao F; Lihua C; Xin L; Shuju T
Indian J Hematol Blood Transfus; 2024 Apr; 40(2):220-230. PubMed ID: 38708154
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Prognostic Model to Predict the Prognosis of Patients With Retroperitoneal Liposarcoma: A Large International Population-Based Cohort Study.
Li Y; Wu G; Zhang Y; Yang W; Wang X; Duan L; Niu L; Chen J; Zhou W; Liu J; Zhong H; Fan D; Hong L
Front Oncol; 2022; 12():857827. PubMed ID: 35719991
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of nomograms by radiomic features on ultrasound imaging for predicting overall survival in patients with primary nodal diffuse large B-cell lymphoma.
Deng H; Zhou Y; Lu W; Chen W; Yuan Y; Li L; Shu H; Zhang P; Ye X
Front Oncol; 2022; 12():991948. PubMed ID: 36568168
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma.
Zhong Q; Shi Y
Front Oncol; 2020; 10():582567. PubMed ID: 33520698
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a prognostic scoring system for patients with colorectal cancer hepato-pulmonary metastasis: a retrospective study.
Deng S; Jiang Z; Cao Y; Gu J; Mao F; Xue Y; Qin L; Liu K; Wang J; Wu K; Cai K
BMC Cancer; 2022 Jun; 22(1):643. PubMed ID: 35690752
[TBL] [Abstract][Full Text] [Related]
16. A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study.
Shi H; Chen Z; Dong S; He R; Du Y; Qin Z; Zhou W
BMC Gastroenterol; 2022 Jun; 22(1):279. PubMed ID: 35658912
[TBL] [Abstract][Full Text] [Related]
17. A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma.
Liu Y; Sheng L; Hua H; Zhou J; Zhao Y; Wang B
Cancer Manag Res; 2023; 15():651-666. PubMed ID: 37465083
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Factor Analysis and Model Construction of Triple-Negative Metaplastic Breast Carcinoma After Surgery.
Zhu K; Chen Y; Guo R; Dai L; Wang J; Tang Y; Zhou S; Chen D; Huang S
Front Oncol; 2022; 12():924342. PubMed ID: 35814407
[TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of a novel nomogram for survival prediction of ovarian carcinosarcoma.
Liu Y; Lin X; Xue L; Wen Y; Wang S; Wang X
Transl Cancer Res; 2022 Jan; 11(1):52-62. PubMed ID: 35261884
[TBL] [Abstract][Full Text] [Related]
20. [Clinical Characteristics and Prognostic Factors of Patients with Primary Parotid Gland Lymphoma].
Xu P; Liu J; Chen HJ; Shang LM; Yan F; Xie XB; Gu WY; Lin Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):1077-1084. PubMed ID: 37551480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
